X0306 4 2018-08-30 0 0001619087 SteadyMed Ltd. STDY 0001637025 SteadyMed Investors, LLC C/O STEADYMED LTD. 2603 CAMINO RAMON, SUITE 350 SAN RAMON CA 94583 0 0 1 0 Ordinary Shares 2018-08-30 4 S 0 266257 4.46 D 0 I See Footnote. Ordinary Shares 2018-08-30 4 S 0 2088258 4.46 D 0 I See Footnote. Ordinary Shares 2018-08-30 4 S 0 181025 4.46 D 0 I See Footnote. Warrants to Purchase Ordinary Shares 3.5995 2018-08-30 4 J 0 266257 0.125 D 2021-08-03 Ordinary Shares 266527 0 I See Footnote. Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). Under the Merger Agreement, at the effective time of the merger (the "Effective Time"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a "CVR"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the "Milestone"). By SteadyMed Investors III LLC, an affiliate of SteadyMed Investors, LLC. By SteadyMed Investors, LLC. KB Partners, LLC is the Managing Member and the Reporting Person is the Managing Member of KB Partners, LLC. By SteadyMed Investors II, LLC, an affiliate of SteadyMed Investors LLC. Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation ("United"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the "Merger Agreement"). At the Effective Time, each outstanding warrant to purchase ordinary shares of the Issuer issued in 2016 was converted into the right to receive $2.71. /s/ David W. Nassif, Attorney-In-Fact 2018-09-04